Community-acquired pneumonia in children

Fabio Cardinale, Anna Rita Cappiello, Maria Felicia Mastrototaro, Mariacristina Pignatelli, Susanna Esposito

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Community-acquired pneumonia (CAP) remains a frequent cause of morbidity and mortality worldwide even in industrialised countries, and its incidence is highest among children aged <5. years. Over the last two years, three international guidelines have been updated with new evidence concerning the incidence, aetiology and management of childhood CAP, but there are still some major problems in standardisation. The main aim of this review is to consider the available data concerning the aetiology, diagnosis, evaluation of severity, and treatment of paediatric CAP. Analysis of the literature shows that there are a number of unanswered questions concerning the management of CAP, including its definition, the absence of a paediatric CAP severity score, the difficulty of identifying its aetiology, the emergence of resistance of the most frequent respiratory pathogens to the most widely used anti-infectious agents, and the lack of information concerning the changes in CAP epidemiology following the introduction of vaccines against respiratory pathogens. More research is clearly required in various areas, and further efforts are needed to increase vaccination coverage with the already available vaccines in order to reduce the occurrence of the disease.

Original languageEnglish
JournalEarly Human Development
Volume89
Issue numberSUPPL3
DOIs
Publication statusPublished - Oct 2013

Fingerprint

Pneumonia
Vaccines
Pediatrics
Incidence
Developed Countries
Vaccination
Epidemiology
Guidelines
Morbidity
Mortality
Research
Therapeutics

Keywords

  • Antibiotics
  • Antimicrobial treatment
  • Community-acquired pneumonia
  • Pneumonia
  • Respiratory infection

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynaecology

Cite this

Cardinale, F., Cappiello, A. R., Mastrototaro, M. F., Pignatelli, M., & Esposito, S. (2013). Community-acquired pneumonia in children. Early Human Development, 89(SUPPL3). https://doi.org/10.1016/j.earlhumdev.2013.07.023

Community-acquired pneumonia in children. / Cardinale, Fabio; Cappiello, Anna Rita; Mastrototaro, Maria Felicia; Pignatelli, Mariacristina; Esposito, Susanna.

In: Early Human Development, Vol. 89, No. SUPPL3, 10.2013.

Research output: Contribution to journalArticle

Cardinale, F, Cappiello, AR, Mastrototaro, MF, Pignatelli, M & Esposito, S 2013, 'Community-acquired pneumonia in children', Early Human Development, vol. 89, no. SUPPL3. https://doi.org/10.1016/j.earlhumdev.2013.07.023
Cardinale F, Cappiello AR, Mastrototaro MF, Pignatelli M, Esposito S. Community-acquired pneumonia in children. Early Human Development. 2013 Oct;89(SUPPL3). https://doi.org/10.1016/j.earlhumdev.2013.07.023
Cardinale, Fabio ; Cappiello, Anna Rita ; Mastrototaro, Maria Felicia ; Pignatelli, Mariacristina ; Esposito, Susanna. / Community-acquired pneumonia in children. In: Early Human Development. 2013 ; Vol. 89, No. SUPPL3.
@article{3d35c9e2fc0b4d3587942fd9998e6fcf,
title = "Community-acquired pneumonia in children",
abstract = "Community-acquired pneumonia (CAP) remains a frequent cause of morbidity and mortality worldwide even in industrialised countries, and its incidence is highest among children aged <5. years. Over the last two years, three international guidelines have been updated with new evidence concerning the incidence, aetiology and management of childhood CAP, but there are still some major problems in standardisation. The main aim of this review is to consider the available data concerning the aetiology, diagnosis, evaluation of severity, and treatment of paediatric CAP. Analysis of the literature shows that there are a number of unanswered questions concerning the management of CAP, including its definition, the absence of a paediatric CAP severity score, the difficulty of identifying its aetiology, the emergence of resistance of the most frequent respiratory pathogens to the most widely used anti-infectious agents, and the lack of information concerning the changes in CAP epidemiology following the introduction of vaccines against respiratory pathogens. More research is clearly required in various areas, and further efforts are needed to increase vaccination coverage with the already available vaccines in order to reduce the occurrence of the disease.",
keywords = "Antibiotics, Antimicrobial treatment, Community-acquired pneumonia, Pneumonia, Respiratory infection",
author = "Fabio Cardinale and Cappiello, {Anna Rita} and Mastrototaro, {Maria Felicia} and Mariacristina Pignatelli and Susanna Esposito",
year = "2013",
month = "10",
doi = "10.1016/j.earlhumdev.2013.07.023",
language = "English",
volume = "89",
journal = "Early Human Development",
issn = "0378-3782",
publisher = "Elsevier Ireland Ltd",
number = "SUPPL3",

}

TY - JOUR

T1 - Community-acquired pneumonia in children

AU - Cardinale, Fabio

AU - Cappiello, Anna Rita

AU - Mastrototaro, Maria Felicia

AU - Pignatelli, Mariacristina

AU - Esposito, Susanna

PY - 2013/10

Y1 - 2013/10

N2 - Community-acquired pneumonia (CAP) remains a frequent cause of morbidity and mortality worldwide even in industrialised countries, and its incidence is highest among children aged <5. years. Over the last two years, three international guidelines have been updated with new evidence concerning the incidence, aetiology and management of childhood CAP, but there are still some major problems in standardisation. The main aim of this review is to consider the available data concerning the aetiology, diagnosis, evaluation of severity, and treatment of paediatric CAP. Analysis of the literature shows that there are a number of unanswered questions concerning the management of CAP, including its definition, the absence of a paediatric CAP severity score, the difficulty of identifying its aetiology, the emergence of resistance of the most frequent respiratory pathogens to the most widely used anti-infectious agents, and the lack of information concerning the changes in CAP epidemiology following the introduction of vaccines against respiratory pathogens. More research is clearly required in various areas, and further efforts are needed to increase vaccination coverage with the already available vaccines in order to reduce the occurrence of the disease.

AB - Community-acquired pneumonia (CAP) remains a frequent cause of morbidity and mortality worldwide even in industrialised countries, and its incidence is highest among children aged <5. years. Over the last two years, three international guidelines have been updated with new evidence concerning the incidence, aetiology and management of childhood CAP, but there are still some major problems in standardisation. The main aim of this review is to consider the available data concerning the aetiology, diagnosis, evaluation of severity, and treatment of paediatric CAP. Analysis of the literature shows that there are a number of unanswered questions concerning the management of CAP, including its definition, the absence of a paediatric CAP severity score, the difficulty of identifying its aetiology, the emergence of resistance of the most frequent respiratory pathogens to the most widely used anti-infectious agents, and the lack of information concerning the changes in CAP epidemiology following the introduction of vaccines against respiratory pathogens. More research is clearly required in various areas, and further efforts are needed to increase vaccination coverage with the already available vaccines in order to reduce the occurrence of the disease.

KW - Antibiotics

KW - Antimicrobial treatment

KW - Community-acquired pneumonia

KW - Pneumonia

KW - Respiratory infection

UR - http://www.scopus.com/inward/record.url?scp=84887139561&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887139561&partnerID=8YFLogxK

U2 - 10.1016/j.earlhumdev.2013.07.023

DO - 10.1016/j.earlhumdev.2013.07.023

M3 - Article

VL - 89

JO - Early Human Development

JF - Early Human Development

SN - 0378-3782

IS - SUPPL3

ER -